|Articles|September 1, 2004
- Pharmaceutical Executive-09-01-2004
September Table of Contents
September Table of Contents
Advertisement
Articles in this issue
over 21 years ago
September Table of Contentsover 21 years ago
(Huge) Untapped Opportunityover 21 years ago
Information Into Actionover 21 years ago
Halting the Hypeover 21 years ago
Spend Trends: A $20 Billion Bill and Plenty of Changeover 21 years ago
From the Mouths of Babesover 21 years ago
Safe and Secureover 21 years ago
Synta's Surpriseover 21 years ago
The New Building Blocks for Blockbustersover 21 years ago
Specialty Therapies Lose Special StatusNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
2
What Governance Resets Should Pharma Companies Take in Response to AI?
3
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
4
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
5